Showing results (21-30 of 5,446) with videos related to
Sort By:
Pageof 545
Leukemia|May 30, 2008
Treatment of plasma cell dyscrasias with lenalidomideM A Dimopoulos, E Kastritis, S V RajkumarLeukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.Leukemia|December 24, 2011
Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whitesA J Greenberg, C M Vachon, S V RajkumarMayo Clinic Proceedings|June 11, 1998
Diagnostic value of albumin gene expression in liver tumors: case report and review of the literatureS V Rajkumar, R L Richardson, J R GoellnerThe American Journal of Medicine|April 29, 1998
Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathyS V Rajkumar, M A Gertz, R A KyleCancer|April 29, 1998
Primary systemic amyloidosis with delayed progression to multiple myelomaS V Rajkumar, M A Gertz, R A KyleLeukemia|April 27, 2007
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cellsM P Kline, S V Rajkumar, M M Timm, et al.Leukemia|August 10, 2011
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphomaV Ramakrishnan, S Ansell, J Haug, et al.Oncogene|November 26, 2009
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugsV Ramakrishnan, M Timm, J L Haug, et al.Pageof 545